Log in to save to my catalogue

Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumi...

Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1691983703

Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles

About this item

Full title

Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles

Publisher

New York: Springer US

Journal title

Medical oncology (Northwood, London, England), 2015-07, Vol.32 (7), p.208, Article 208

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Today, using nanoparticle-based drug delivery systems has expanded to avoid anticancer side effects. Taxanes are important chemotherapeutic agents in the treatment of metastatic breast cancer. In this study, docetaxel (DTX)-loaded human serum albumin (HSA) nanoparticles (NPs) were prepared and characterized. Drug toxicity of the nanoparticles was m...

Alternative Titles

Full title

Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1691983703

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1691983703

Other Identifiers

ISSN

1357-0560

E-ISSN

1559-131X

DOI

10.1007/s12032-015-0652-5

How to access this item